Wednesday, July 8, 2026

pharma · Atopic Dermatitis · Alopecia Areata

Forteo

Forteo clinical programs — 5 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Las Vegas, USA HQ
20 Employees
PMDA registrant Type
Company details
Status
Public
HQ
Las Vegas, USA
Employees
20
Programs
5
Drugs
0
Patents
3
Intelligence · Clinical Programs

Forteo projects

5 ClinicalTrials.gov programs sponsored by Forteo.

Forteo has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. FB-401

    Forteo

    Atopic Dermatitis

    phase 2 mab terminated

    2 trials
  2. FB102

    Forteo

    Celiac Disease

    phase 2 mab active

    1 trial
  3. FB102

    Forteo

    Alopecia Areata

    phase 1 small molecule active

    1 trial
  4. FB102

    Forteo

    Vitiligo

    phase 1 small molecule active

    1 trial
  5. Signature Cord Prime

    Forteo

    Osteoarthritis, Knee

    phase 1 mab active

    1 trial

Frequently asked questions

How many clinical projects does Forteo have?

5 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.